Literature DB >> 2016086

Assessment of a creatine kinase isoform M defect as a cause of myotonic dystrophy and the characterization of two novel CKMM polymorphisms.

J Bailly1, A E MacKenzie, S Leblond, R G Korneluk.   

Abstract

Recent studies have shown the gene encoding creatine kinase isoform M (CKMM) to be very closely linked to the myotonic dystrophy (DM) locus on the long arm of chromosome 19. Given this close linkage to DM and the postulated role of CKMM in skeletal muscle contraction, the possibility of a defect in CKMM causing DM was investigated. CKMM cDNA was isolated from the skeletal muscle of an individual with DM. Sequencing of the CKMM cDNA from the DM chromosome 19 revealed two novel polymorphisms but no translationally significant mutation. This work rules out a defect in the coding segment of CKMM as a cause of DM in this family and, in light of genetic homogeneity shown to date for DM, probably in all cases of DM.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2016086     DOI: 10.1007/bf00194633

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  24 in total

1.  Kinetic properties and the functional role of particulate MM-isoenzyme of creatine phosphokinase bound to heart muscle myofibrils.

Authors:  V A Saks; G B Chernousova; R Vetter; V N Smirnov; E I Chazov
Journal:  FEBS Lett       Date:  1976-03-01       Impact factor: 4.124

2.  Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS).

Authors:  C R Newton; A Graham; L E Heptinstall; S J Powell; C Summers; N Kalsheker; J C Smith; A F Markham
Journal:  Nucleic Acids Res       Date:  1989-04-11       Impact factor: 16.971

3.  Direct sequencing from low-melt agarose with Sequenase.

Authors:  K A Kretz; G S Carson; J S O'Brien
Journal:  Nucleic Acids Res       Date:  1989-07-25       Impact factor: 16.971

4.  'One minute' transformation of competent E. coli by plasmid DNA.

Authors:  E I Golub
Journal:  Nucleic Acids Res       Date:  1988-02-25       Impact factor: 16.971

5.  Errors in the polymerase chain reaction.

Authors:  A M Dunning; P Talmud; S E Humphries
Journal:  Nucleic Acids Res       Date:  1988-11-11       Impact factor: 16.971

6.  Developmental regulation and tissue-specific expression of the human muscle creatine kinase gene.

Authors:  R V Trask; A W Strauss; J J Billadello
Journal:  J Biol Chem       Date:  1988-11-15       Impact factor: 5.157

7.  A subcloning strategy for DNA sequence analysis.

Authors:  A M Frischauf; H Garoff; H Lehrach
Journal:  Nucleic Acids Res       Date:  1980-12-11       Impact factor: 16.971

8.  Isoenzyme-specific localization of M-line bound creatine kinase in myogenic cells.

Authors:  T Wallimann; H Moser; H M Eppenberger
Journal:  J Muscle Res Cell Motil       Date:  1983-08       Impact factor: 2.698

9.  Myotonic dystrophy is closely linked to the gene for muscle-type creatine kinase (CKMM).

Authors:  H G Brunner; R G Korneluk; M Coerwinkel-Driessen; A MacKenzie; H Smeets; H M Lambermon; B A van Oost; B Wieringa; H H Ropers
Journal:  Hum Genet       Date:  1989-03       Impact factor: 4.132

10.  Isolation and sequence analysis of a full-length cDNA for human M creatine kinase.

Authors:  M B Perryman; S A Kerner; T J Bohlmeyer; R Roberts
Journal:  Biochem Biophys Res Commun       Date:  1986-11-14       Impact factor: 3.575

View more
  3 in total

Review 1.  Molecular biology of neurological diseases.

Authors:  W J Cumming
Journal:  Postgrad Med J       Date:  1992-04       Impact factor: 2.401

2.  Mutation screening of spastin, atlastin, and REEP1 in hereditary spastic paraplegia.

Authors:  D S McCorquodale; U Ozomaro; J Huang; G Montenegro; A Kushman; L Citrigno; J Price; F Speziani; M A Pericak-Vance; S Züchner
Journal:  Clin Genet       Date:  2011-06       Impact factor: 4.438

Review 3.  Role of creatine kinase isoenzymes on muscular and cardiorespiratory endurance: genetic and molecular evidence.

Authors:  M Echegaray; M A Rivera
Journal:  Sports Med       Date:  2001       Impact factor: 11.928

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.